Unfortunately, in thesetting of SARS-CoV-2, ACE-2 is no longer available due to viral binding andthus, angiotensin 2 will exert its role in the development of severe lung injuryassociated with COVID-19 [15, 17]. The gene discussed is ACE2; the disease is COVID-19.